Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TC Biopharm (Holdings) PLC TCBP

Healthcare Biotechnology
TC BioPharm (Holdings) plc, formerly TC BioPharm (Holdings) Limited, is a clinical-stage biopharmaceutical company. The Company is focused on developing immunotherapy products that are based on its allogeneic gamma delta T (GD-T) cell platform. Harnessing the innate ability of GD-Ts, the Company has developed a range of clinical-stage cell therapies designed to combat identified cancers and... see more

NDAQ:TCBP - Post Discussion

TC Biopharm (Holdings) PLC > TC BioPharm Announces Pricing of $2.0 Registered Direct Offe
View:
Post by whytestocks on Aug 13, 2024 5:47pm

TC BioPharm Announces Pricing of $2.0 Registered Direct Offe

BREAKING NEWS: $TCBP TC BioPharm Announces Pricing of $2.0 Registered Direct OfferingTC BioPharm Announces Pricing of $2.0 Registered Direct Offering PR Newswire EDINBURGH, Scotland , Aug. 13, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing plat...TCBP - TC BioPharm Announces Pricing of $2.0 Registered Direct Offering
Be the first to comment on this post
TC Biopharm (Holdings) PLC
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities